Perforomist and Alvesco drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perforomist (formoterol fumarate) and Alvesco (ciclesonide). Common drug interactions include pneumonia among females and rash erythematous among males.

The phase IV clinical study analyzes what interactions people have when they take Perforomist and Alvesco. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Perforomist?

Perforomist has active ingredients of formoterol fumarate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 1,431 Perforomist users. Check the latest studies of Perforomist.

What is Alvesco?

Alvesco has active ingredients of ciclesonide. It is often used in asthma. eHealthMe is studying from 13,134 Alvesco users. Check the latest studies of Alvesco.

On Jul, 17, 2026

13 people who take Perforomist and Alvesco together, and have interactions are studied.

Perforomist and Alvesco drug interactions.

What are the common drug interactions of Perforomist and Alvesco, by gender? *:

female:

Pneumonia
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Sinusitis (inflammation of sinus)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Herpes zoster
Nasopharyngitis (inflammation of the nasopharynx)
Productive cough
Anticholinergic syndrome (absolute or relative reduction in cholinergic activity in the central nervous system)
Cardiac failure congestive
Cystitis (inflammation of the wall of the bladder)

male:

Rash erythematous (redness of the skin)

What are the common drug interactions of Perforomist and Alvesco, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Nasopharyngitis (inflammation of the nasopharynx)
Pneumonia
Productive cough
Sinusitis (inflammation of sinus)
Anticholinergic syndrome (absolute or relative reduction in cholinergic activity in the central nervous system)
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Micturition frequency decreased (less frequency of urinate)

50-59:

Urticaria (rash of round, red welts on the skin that itch intensely)
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Blindness
Blood pressure decreased
Blood pressure increased
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Pneumonia
Throat tightness

60+:

Herpes zoster
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 46.15%
Hypersensitivity: 6 people, 46.15%
High Blood Pressure: 5 people, 38.46%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 30.77%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 30.77%
Depression: 4 people, 30.77%
Stable Angina (a constant chest pain): 4 people, 30.77%
High Blood Cholesterol: 2 people, 15.38%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 15.38%
Migraine (headache): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Perforomist and Alvesco?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously